Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2025-12-25 @ 3:13 AM
NCT ID:
NCT02074605
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with high risk malignant melanoma (defined as American Joint Committee on Cancer Stage IIb or greater) electing to undergo treatment with either adjuvant interferon alpha-2b, or observation only.
* Age 18 years or older.
* Karnofsky performance status greater than 60.
* Fluent English speaker.
Exclusion Criteria:
* History of neurologic or psychiatric disease that will affect patient's ability to complete protocol tests.
* Clinical or radiological evidence of brain metastasis.
* Any condition, which in the opinion of the investigator makes the subject unsuitable for study participation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02074605
Study Brief:
Protocol Section:
NCT02074605